Evidence map›Paper›PMID 40940916›Full record

ReviewCancers2025

Modern Approaches to Rectal Cancer: Integrating Endoscopic, Surgical, and Oncological Care.

Jiří Kotek, Jiří Cyrany, Miroslav Sirový, Pavel Novotný, Jiří Páral

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiří KotekDepartment of Surgery, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.ORCID 0000-0002-5391-0572
Jiří CyranyDepartment of Surgery and Gastroenterology, Faculty of Medicine in Hradec Králové, Charles University, 11636 Prague, Czech Republic.
Miroslav SirovýDepartment of Surgery, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.ORCID 0000-0003-2030-0687
Pavel NovotnýDepartment of Surgery, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.
Jiří PáralDepartment of Surgery, University Hospital Hradec Králové, 50005 Hradec Králové, Czech Republic.

Funding

Ministry of Defence of the Czech Republic "Long Term Organization Development Plan 1011" - Clinical Branches II of the Military Faculty of Medicine Hradec Kralove, University of Defence, Czech Republic
6 · The paper itself

Abstract

Rectal cancer remains a significant clinical challenge due to its complex anatomy and the critical need to balance oncological radicality with functional preservation. Multimodal treatment strategies, including neoadjuvant therapy, advanced endoscopic techniques, and precise surgical approaches, have evolved to optimize patient outcomes. Neoadjuvant chemoradiotherapy improves resectability and local control in locally advanced tumors, while endoscopic treatment offers organ-preserving options for carefully selected early-stage cancers. Surgical resection, primarily through total mesorectal excision (TME), remains the cornerstone of curative therapy, with minimally invasive and transanal approaches enhancing precision and recovery. In advanced and recurrent cases, extended procedures such as pelvic exenteration provide potential for cure despite substantial morbidity. This review summarizes current evidence on the indications, techniques, and outcomes of neoadjuvant, endoscopic, and surgical treatments for rectal cancer, emphasizing individualized treatment planning to achieve optimal oncological and functional results.

Indexed as

endoscopic treatmentminimally invasive surgeryneoadjuvant therapyorgan preservationpelvic exenterationrectal cancertotal mesorectal excisiontransanal surgery

Identifiers

PMID40940916
PMCPMC12427191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.